68 results
Page 3 of 4
6-K
EX-99.3
dskylcluz01q
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
mo4 fsog3
6 Aug 20
Report of Foreign Private Issuer
4:02pm
6-K
EX-1.1
pcyazw
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm
424B5
k0je1bm wy1sf8t8lkdk
20 May 20
Prospectus supplement for primary offering
4:08pm
6-K
7ngw18f6bojq
18 May 20
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
4:12pm
424B5
hm1 ucsfjusl
18 May 20
Prospectus supplement for primary offering
4:11pm
F-3
EX-1.2
ks3klb8hig5mi7f41
14 Nov 19
Shelf registration (foreign)
5:11pm
424B4
n7tck3nef 2znr
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
opktd0udxc0h
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-1.1
e7yl7pf
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
gwvpivdyie53w6a3
24 Jun 19
Registration statement (foreign)
4:04pm
CORRESP
4q3b6s fyqcbeb8hlcek
24 Jun 19
Correspondence with SEC
12:00am
6-K
EX-99.1
bse6g6k
19 Jun 19
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
6:02am
6-K
EX-99.1
sekj vwh1blq485gpy
1 May 19
Current report (foreign)
7:23am
6-K
u8qz6n
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
6-K
EX-99.1
cl1z3sjchrl
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
wyceg6f 0q6a
25 Feb 19
Annual report (foreign)
5:08pm
UPLOAD
tepmvdrhby8h9zl
25 Feb 19
Letter from SEC
12:00am
DRS
yt6w2wsmgvwwyx0za
15 Feb 19
Draft registration statement
12:00am